STOCK TITAN

IMMUTEP Ltd (IMMP) COO reports 2.87M shares and 1.8M rights

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

IMMUTEP Ltd Chief Operating Officer Deanne Diem Miller reported her initial ownership on a Form 3. She directly holds 2,867,305 Ordinary Shares. In addition, she holds 1,800,000 performance rights, each giving a right to receive Ordinary Shares at an exercise price of $0.0000 per share.

These performance rights are structured in three equal tranches of 600,000 underlying Ordinary Shares each, scheduled to vest on December 1, 2026, December 1, 2027, and December 1, 2028. Vesting of the later tranches depends on Ms. Miller achieving specified key performance indicators at the applicable vesting dates.

Positive

  • None.

Negative

  • None.
Insider Miller Deanne Diem
Role Chief Operating Officer
Type Security Shares Price Value
holding Performance rights (right to receive) -- -- --
holding Performance rights (right to receive) -- -- --
holding Performance rights (right to receive) -- -- --
holding Ordinary Shares -- -- --
Holdings After Transaction: Performance rights (right to receive) — 600,000 shares (Direct); Ordinary Shares — 2,867,305 shares (Direct)
Footnotes (1)
  1. Granted on December 5, 2024. 600,000 performance rights will vest on December 1, 2026 and the vesting of the remaining 1,200,000 performance rights is dependent on Ms. Miller achieving key performance indicators at the applicable vesting date. Granted on December 5, 2024. 600,000 performance rights will vest on December 1, 2027 and the vesting of the remaining 600,000 performance rights is dependent on Ms. Miller achieving key performance indicators at the applicable vesting date. Granted on December 5, 2024. 600,000 performance rights will vest on December 1, 2028 and the vesting is dependent on Ms. Miller achieving key performance indicators at the applicable vesting date.
Ordinary Shares held 2,867,305 shares Direct ownership following transactions
Total performance rights 1,800,000 rights Rights to receive Ordinary Shares at $0.0000
First performance rights tranche 600,000 underlying shares Scheduled to vest on December 1, 2026
Second performance rights tranche 600,000 underlying shares Scheduled to vest on December 1, 2027; KPI dependent for remaining rights
Third performance rights tranche 600,000 underlying shares Scheduled to vest on December 1, 2028; KPI dependent
Exercise price of performance rights $0.0000 per share Applies to all reported performance rights
Performance rights financial
"Performance rights (right to receive)"
Performance rights are conditional awards that give employees or executives the promise of receiving company shares or cash only if the business meets specific targets or survives for a set period. They work like a bonus you only get when certain goals are hit, so they matter to investors because they can increase the number of shares outstanding (dilution), signal management’s incentives and confidence in future results, and affect per-share earnings and valuation.
Ordinary Shares financial
"underlying_security_title: "Ordinary Shares""
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.
vesting financial
"600,000 performance rights will vest on December 1, 2026"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
key performance indicators financial
"dependent on Ms. Miller achieving key performance indicators"
Key performance indicators are specific measurements used to track how well a person, team, or organization is achieving its goals. They act like report cards, providing clear signs of progress or areas needing improvement. For investors, KPIs help assess the health and future potential of a business by highlighting its most important strengths and challenges.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Miller Deanne Diem

(Last)(First)(Middle)
LEVEL 32, AUSTRALIA SQUARE,
264 GEORGE STREET

(Street)
SYDNEY, NEW SOUTH WALESAUSTRALIA2000

(City)(State)(Zip)

AUSTRALIA

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
IMMUTEP Ltd [ IMMP ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Operating Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares2,867,305D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Performance rights (right to receive)(1)12/01/202612/05/2029Ordinary Shares600,000$0D
Performance rights (right to receive)(2)12/01/202712/05/2029Ordinary Shares600,000$0D
Performance rights (right to receive)(3)12/01/202812/05/2029Ordinary Shares600,000$0D
Explanation of Responses:
1. Granted on December 5, 2024. 600,000 performance rights will vest on December 1, 2026 and the vesting of the remaining 1,200,000 performance rights is dependent on Ms. Miller achieving key performance indicators at the applicable vesting date.
2. Granted on December 5, 2024. 600,000 performance rights will vest on December 1, 2027 and the vesting of the remaining 600,000 performance rights is dependent on Ms. Miller achieving key performance indicators at the applicable vesting date.
3. Granted on December 5, 2024. 600,000 performance rights will vest on December 1, 2028 and the vesting is dependent on Ms. Miller achieving key performance indicators at the applicable vesting date.
Deanne Diem Miller04/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What equity holdings did IMMUTEP (IMMP) COO Deanne Miller report on this Form 3?

Deanne Diem Miller reported direct ownership of 2,867,305 Ordinary Shares of IMMUTEP Ltd. She also reported 1,800,000 performance rights, each representing a right to receive Ordinary Shares, providing significant equity-based exposure alongside her existing shareholding.

How many performance rights does IMMUTEP (IMMP) COO Deanne Miller hold and how are they structured?

She holds 1,800,000 performance rights, split into three equal tranches of 600,000 underlying Ordinary Shares each. All carry an exercise price of $0.0000 per share and are scheduled to vest over several future dates, subject to performance conditions.

When do Deanne Miller’s IMMUTEP (IMMP) performance rights vest?

The performance rights vest in three stages: 600,000 on December 1, 2026, 600,000 on December 1, 2027, and 600,000 on December 1, 2028. Each vesting date represents a potential future issuance of Ordinary Shares to her.

Are Deanne Miller’s IMMUTEP (IMMP) performance rights subject to performance conditions?

Yes. The footnotes state that vesting of 1,200,000 performance rights tied to 2027 and 2028 dates depends on Ms. Miller achieving key performance indicators at the applicable vesting dates. This links a large part of her potential equity to company and role performance.

What is the exercise price of IMMUTEP (IMMP) COO Deanne Miller’s performance rights?

The performance rights carry an exercise price of $0.0000 per underlying Ordinary Share. This means that, upon vesting and satisfaction of conditions, shares can be received without additional cash outlay, aligning compensation with equity value rather than purchase cost.

Does this IMMUTEP (IMMP) Form 3 show any recent share purchases or sales by Deanne Miller?

No recent purchases or sales are indicated. The transactions are classified as holding entries with an unknown transaction code, showing her existing Ordinary Share position and performance rights rather than open-market buys or sells.